ESC 365 - Antithrombotic and anticoagulant treatment following TAVI/TAVR – considerations, recommendations & unmet needs.

ESC Premium Access

Antithrombotic and anticoagulant treatment following TAVI/TAVR – considerations, recommendations & unmet needs.

Session: Leaflet thrombosis following bioprosthetic valve replacement: storm in a teacup?

Topic: Intervention

Speaker: Doctor J. Rodes-Cabau (Quebec, CA)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Josep Rodes-Cabau

Quebec Heart and Lung Institute, Quebec (Canada)

6 presentations

0 follower

4 more presentations in this session

The pathology of leaflet thrombosis.

Speaker: Doctor M. Joner (Munich, DE)

Imaging assessment of leaflet thrombosis and pannus.

Speaker: Doctor A. Moss (Leicester, GB)

Clinical Implications of leaflet thrombosis following surgical and transcatheter aortic valve replacement – what are the current data?

Speaker: Professor H. Eltchaninoff (Rouen, FR)

Panel discussion.

Access the full session

Leaflet thrombosis following bioprosthetic valve replacement: storm in a teacup?

Speakers: Doctor J. Rodes-Cabau, Doctor M. Joner, Doctor A. Moss, Professor H. Eltchaninoff

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources